[Treatment of sepsis-induced coagulopathy : Results of a Germany-wide survey in intensive care units].

ABSTRACT:

Background

In the context of sepsis and septic shock, coagulopathy often occurs due to the close relationship between coagulation and inflammation. Sepsis-induced coagulopathy (SIC) is the most severe and potentially fatal form. Anticoagulants used in prophylactic or therapeutic doses are discussed to potentially exert beneficial effects in patients with sepsis and/or SIC; however, due to the lack of evidence recent guidelines are limited to recommendations for drug prophylaxis of venous thromboembolism (VTE), while treatment of SIC has not been addressed.

Methods

In order to determine the status quo of VTE prophylaxis as well as treatment of SIC in German intensive care units (ICU), we conducted a Germany-wide online survey among heads of ICUs from October 2019 to May 2020.

SUBMITTER: Schmoch T 

PROVIDER: S-EPMC7869761 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature